ICG invests in Loparex alongside the company's leadership team

Loparex is a manufacturer of release liners and films, and is headquartered in The Netherlands, with manufacturing sites in Europe, Thailand, China, India and the US.

ICG is a specialist asset manager providing subordinated structured lending, private debt, leveraged credit and minority equity, managing 14.9 billion EUR (16.1 billion USD) of assets in third party funds and proprietary capital.

The investment in Loparex will be made through ICG Europe Fund V, and Loparex will be the final investment of the fund. ICG is investing alongside the company’s management team and a group of private investors.

ICG sees release liner markets as ‘attractive with above GDP growth and constantly evolving new application areas’, and said Loparex is the only manufacturer of release liners with production facilities across North America, Europe and the Asia-Pacific region. Loparex has a strong reputation for product innovation and is recognized as a technology leader in its industry, ICG added.

Benoit Durteste, managing director and head of European investments at ICG, said: ‘Loparex is a leading company in its specialist area of manufacturing with an excellent management team, a strong strategy and business model.

‘ICG is delighted to be investing in this company and looks forward to being part of the next phase of Loparex’s development. Loparex is well positioned to maintain and grow its market leadership.

‘We see great opportunities ahead both through organic growth and market consolidation.’

Following the transaction AAC Capital Partners will no longer be a shareholder in Loparex, having owned the company since 2005.

Michael Apperson, Loparex chief executive officer, said: ‘All of us at Loparex are very excited about this ownership transition, and we look forward to the support of ICG in our continued commitment to producing the world’s broadest portfolio of release liners to support long term growth with our global customers.’